drugset / Trial / NCT01742520

Neurodevelopmental Outcomes of Preterm Infants Treated for Pain Management With Repeated Doses of Sucrose 24%

NCT01742520

Unknown 90 enrolled Sheba Medical Center
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to determine the effect of sucrose 24% for pain prevention on preterm infants. Our hypothesis is that repeated doses of sucrose 24%, given prior to painful procedure,do not impair neurodevelopmental outcomes of preterm infants

Timeline

Start
2013-01
Primary completion
2014-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sucrose Small molecule 0.5 ml Oral
Comparator Sucrose Small molecule 1 ml Oral

Indications

No indication recorded.